AIC
TECH icon

Ameritas Investment Company’s Bio-Techne TECH Stock Holding History

Ameritas Investment Company’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$337K Buy
2,780
+1,036
+59% +$126K 0.02% 527
2021
Q2 		$2.69M Buy
1,744
+860
+97% +$90.5K 0.13% 132
2021
Q1 		$84.4K Buy
+884
New +$80.6K 0.01% 802
2019
Q1 		– Sell
-40
Closed -$1K – 1710
2018
Q4 		$1K Buy
+40
New +$1.67K ﹤0.01% 1457

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ameritas Investment Company's TECH Position: Q3 2021 in Review

Ameritas Investment Company increased its Bio-Techne (TECH) stake by 59% in Q3 2021, buying an estimated $126K and bringing the position to 2,780 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #527.

Ameritas Investment Company first reported a position in TECH in Q4 2018 and has held it in 4 quarters since. The position peaked at $2.69M in Q2 2021. 566 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • Ameritas Investment Company held 2,780 shares of Bio-Techne worth $337K as of Q3 2021.
  • Ameritas Investment Company bought 1,036 Bio-Techne shares in Q3 2021, an estimated $126K.
  • Bio-Techne made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #527 holding.
  • Ameritas Investment Company first reported a position in Bio-Techne in Q4 2018 and has held it in 4 quarters since.
  • Ameritas Investment Company's Bio-Techne position peaked at $2.69M in Q2 2021.
  • 566 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.